• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
  • Digital Health
  • Economics of Innovation
  • Mental Health

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

image option 1
Read more
  • Precision Medicine
  • Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

NGS report_AdobeStock_406823942_portrait
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Roche AMR diangostics_national-cancer-institute-2fyeLhUeYpg-unsplash_portrait
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

RWE_clay-banks-b5S4FrJb7yQ-unsplash_portrait
Read more
  • Value-Based Pricing
  • Economics of Innovation
  • Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Triple_Win_AdobeStock_249059909_portrait_v2
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 27th February 2015

OHE Briefing on Incentives to Follow Best Practice in Health Care

OHE has published a Briefing by Karlsberg Schaffer, Sussex and Feng summarising the evidence on incentives that encourage providers of health care to follow guidance on best practice. There has been long-standing interest in the use of incentives to encourage…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

OHE has published a Briefing by Karlsberg Schaffer, Sussex and Feng summarising the evidence on incentives that encourage providers of health care to follow guidance on best practice.

There has been long-standing interest in the use of incentives to encourage delivery of high-quality health care services at the lowest feasible cost. Although it is clear that health care professionals have intrinsic incentives to deliver high-quality care to patients, there are significant variations in quality standards achieved in practice, indicating that a desire to see patients thrive is on its own insufficient to ensure uniformly high standards of care. It is important that the health system provides incentives to add to intrinsic motivation.
 
OHE has published a Briefing by Karlsberg Schaffer, Sussex and Feng summarising the evidence on incentives that encourage providers of health care to follow guidance on best practice, particularly where that guidance requires the use of specific medicines or other health technologies. These incentives include monetary and non-monetary rewards.
 
In the first section of the Briefing, the authors report the results of a review of empirical evidence on the impact of incentives for best practice that have been in operation in health services in the UK and other high-income economies. Where it was feasible to pick out evidence on particular incentive schemes from the literature, these are categorised according to setting; type of financial incentive; domain (clinical or patient experience); number of studies; direction of effect; and quality of evidence.
 
In the second section, the authors describe incentives for best practice that are currently in place in the NHS, particularly in England, in primary and secondary care respectively. Programmes of incentives for which there is good published evidence of their impact include the Quality and Outcomes Framework (QOF) in primary care and CQUINs and Advancing Quality in secondary care.
 
The authors then use the information presented in the previous sections to consider the extent to which health care in the UK might be improved by using additional or modified incentives to encourage providers to follow best-practice guidance. With regard to financial incentives in particular, the Briefing lists a number features of pay-for-performance programmes that are associated with positive results, including use in chronic care (as opposed to acute care) and incentivising clinical outcomes (rather than those relating to patient experience).
 
The authors end by stating that, although the evidence is far from conclusive, there appears to be scope for the introduction of additional policies and the modification of current incentives to reduce variation in, and improve average levels of, adherence to best-practice guidance.
 
The OHE Briefing may be downloaded free here.
 
  • Health Care Systems
  • Policy, Organisation and…
  • Briefing

Related News

  • News
  • May 2019

OHE Launches Discussion Paper and Consultation Exercise on Indication-based Pricing

Read more
  • News
  • April 2019

Quality of Life and Rare Disease: Lessons from Spinal Muscular Atrophy

Read more
  • News
  • November 2018

Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe

Read more
  • News
  • September 2018

Private Provision of Publicly Funded Health Care: The Economics of Ownership

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!